Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1

Status

Completed 7Terminated 5Unknown 4Active not recruiting 4Withdrawn 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Plasma cell 5Thoracic 1Genitourinary 1

Conditions

Multiple Myeloma 5Neoplasms, Plasma Cell 1

Interventions

Dexamethasone 116Bortezomib 63Cyclophosphamide 51Lenalidomide 49Calcium Dobesilate 46Melphalan 37pomalidomide 36fludarabine 28Filgrastim 26fludarabine phosphate 23carfilzomib 22daratumumab 21Whole-Body Irradiation 17Granulocyte Colony-Stimulating Factor 17Mycophenolic Acid 15Antilymphocyte Serum 15dexamethasone acetate 14Tacrolimus 14Thalidomide 13Cyclosporine 13Busulfan 13Radiotherapy 12Peripheral Blood Stem Cell Transplantation 12ixazomib 11dexamethasone 21-phosphate 10auricularum 10pembrolizumab 9Stem Cell Transplantation 9Rituximab 9Etoposide 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Terminated × Clarithromycin × Plasma cell × Clear all
NCT02188368 2023-11-03

Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma Patients

Oncotherapeutics

Phase 2 Terminated
45 enrolled
Plasma cell

Multiple Myeloma

NCT04843579 2023-10-25

ClaSPd

Weill Medical College of Cornell University

Phase 2 Terminated
4 enrolled 9 charts
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT02516696 2023-06-05

BiRd vs Rd

Weill Medical College of Cornell University

Phase 3 Terminated
12 enrolled 19 charts
Plasma cell

Multiple Myeloma

NCT01374217 2018-12-10

Administration of Tadalafil in Conjunction With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated
14 enrolled 8 charts
Plasma cell

Multiple Myeloma

NCT02573935 2016-09-20

CLAIM

Aalborg University Hospital

Phase 2 Terminated
58 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡